Dako Overview

  • Year Founded
  • 1966

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 1,300

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

  • Investments
  • 1

Dako General Information

Description

Manufacturer of reagents, antibodies, instruments and software for use in anatomic pathology laboratories. The company's immunohistochemistry products including antibodies and controls, visualization systems and ancillaries for immunohistochemistry. It also offers pharmacologist kits, molecular pathology products, Special Stains kits and flow cytometry products.

Contact Information

Website
www.dako.com
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • 6392 Via Real
  • Carpinteria, CA 93013
  • United States
+1 (805)
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Corporate Office
  • 6392 Via Real
  • Carpinteria, CA 93013
  • United States
+1 (805)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Dako Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Dako‘s full profile, request access.

Request a free trial

Dako Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of reagents, antibodies, instruments and software for use in anatomic pathology laboratories. The company's
Pharmaceuticals
Carpinteria, CA
1,300 As of 2007

Orth An Der Donau, Austria
 

Amherst, NH
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Dako Competitors (8)

One of Dako’s 8 competitors is Pfizer Manufacturing Austria, a Corporation company based in Orth An Der Donau, Austria.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Pfizer Manufacturing Austria Corporation Orth An Der Donau, Austria
Eagle BioSciences Corporation Amherst, NH
Complete Genomics Formerly VC-backed San Jose, CA
Cell Technology Corporation Hayward, CA
Veracyte Formerly VC-backed South San Francisco, CA
You’re viewing 5 of 8 competitors. Get the full list »

Dako Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Dako Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Dako‘s full profile, request access.

Request a free trial

Dako Investments (1)

Dako’s most recent deal was a Buyout/LBO with Dako InstrumeC. The deal was made on 03-Sep-2008.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Dako InstrumeC 03-Sep-2008 Buyout/LBO Other Healthcare Technology Systems
To view Dako’s complete investments history, request access »

Dako FAQs

  • When was Dako founded?

    Dako was founded in 1966.

  • Where is Dako headquartered?

    Dako is headquartered in Carpinteria, CA.

  • What is the size of Dako?

    Dako has 1,300 total employees.

  • What industry is Dako in?

    Dako’s primary industry is Pharmaceuticals.

  • Is Dako a private or public company?

    Dako is a Private company.

  • What is the current valuation of Dako?

    The current valuation of Dako is .

  • What is Dako’s current revenue?

    The current revenue for Dako is .

  • Who are Dako’s investors?

    EQT, Intermediate Capital Group, and MassVentures have invested in Dako.

  • Who are Dako’s competitors?

    Pfizer Manufacturing Austria, Eagle BioSciences, Complete Genomics, Cell Technology, and Veracyte are some of the 8 competitors of Dako.

  • When was Dako acquired?

    Dako was acquired on 21-Jun-2012.

  • Who acquired Dako?

    Dako was acquired by Agilent Technologies and Beckman Coulter.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »